- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- NAG- MAN: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- FUC: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-FUC.3: 3 residues within 4Å:- Chain B: N.194, T.196, Y.206
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:T.196
NAG-NAG-BMA-MAN-FUC.7: 3 residues within 4Å:- Chain E: N.194, T.196, Y.206
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:T.196
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x CLR: CHOLESTEROL(Non-covalent)
CLR.9: 9 residues within 4Å:- Chain A: F.872, E.880, S.991, F.994
- Chain B: T.61, K.68
- Chain D: L.1005
- Ligands: PCW.31, PCW.33
6 PLIP interactions:1 interactions with chain D, 3 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: D:L.1005, B:T.61, A:F.872
- Hydrogen bonds: B:K.68, B:K.68, A:S.991
CLR.22: 6 residues within 4Å:- Chain A: E.852
- Chain B: R.28, W.33, Y.40, Y.44
- Ligands: PCW.16
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:W.33, B:Y.40, B:Y.44
- Hydrogen bonds: B:R.28, B:R.28
CLR.23: 5 residues within 4Å:- Chain B: G.49, I.52, G.53, Q.56
- Ligands: CLR.43
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:I.52, B:Q.56
CLR.24: 11 residues within 4Å:- Chain A: Y.975, P.990, W.993, F.994, F.997
- Chain C: L.39, G.43, V.46
- Ligands: PCW.12, PCW.28, PCW.48
6 PLIP interactions:5 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: A:P.990, A:W.993, A:F.994, A:F.997, A:F.997, C:V.46
CLR.29: 9 residues within 4Å:- Chain A: L.1005
- Chain D: F.872, E.880, S.991, F.994
- Chain E: T.61, K.68
- Ligands: PCW.11, PCW.13
6 PLIP interactions:2 interactions with chain D, 3 interactions with chain E, 1 interactions with chain A- Hydrophobic interactions: D:F.872, E:T.61, A:L.1005
- Hydrogen bonds: D:S.991, E:K.68, E:K.68
CLR.42: 6 residues within 4Å:- Chain D: E.852
- Chain E: R.28, W.33, Y.40, Y.44
- Ligands: PCW.36
5 PLIP interactions:5 interactions with chain E- Hydrophobic interactions: E:W.33, E:Y.40, E:Y.44
- Hydrogen bonds: E:R.28, E:R.28
CLR.43: 5 residues within 4Å:- Chain E: G.49, I.52, G.53, Q.56
- Ligands: CLR.23
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:I.52, E:Q.56
CLR.44: 11 residues within 4Å:- Chain D: Y.975, P.990, W.993, F.994, F.997
- Chain F: L.39, G.43, V.46
- Ligands: PCW.28, PCW.32, PCW.48
6 PLIP interactions:5 interactions with chain D, 1 interactions with chain F- Hydrophobic interactions: D:P.990, D:W.993, D:F.994, D:F.997, D:F.997, F:V.46
- 22 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PCW.10: 4 residues within 4Å:- Chain A: H.295, H.298, I.299
- Ligands: PCW.16
Ligand excluded by PLIPPCW.11: 18 residues within 4Å:- Chain A: I.865, Y.999, I.1002, L.1005, Y.1006, M.1009, I.1013, G.1020, W.1021, V.1022, Q.1024
- Chain B: K.35, L.38, F.39, F.43, L.47, I.50
- Ligands: CLR.29
Ligand excluded by PLIPPCW.12: 14 residues within 4Å:- Chain A: W.936, F.950, Q.951, G.953, M.954, K.955, T.967, F.997, S.1000, L.1001
- Ligands: PCW.13, CLR.24, PCW.28, PCW.33
Ligand excluded by PLIPPCW.13: 16 residues within 4Å:- Chain A: R.946, S.948, F.950, Q.951, F.1004, L.1005, E.1008, F.1012, R.1015
- Chain D: F.994, L.1001
- Chain E: T.61
- Ligands: PCW.12, CLR.29, PCW.32, PCW.33
Ligand excluded by PLIPPCW.14: 9 residues within 4Å:- Chain A: N.132, Y.136, V.140, V.810, C.814, L.817, V.822, A.982, L.983
Ligand excluded by PLIPPCW.15: 5 residues within 4Å:- Chain A: F.151, Y.154, V.347, T.350, K.354
Ligand excluded by PLIPPCW.16: 16 residues within 4Å:- Chain A: H.295, I.299, V.303, L.307, F.311, L.796, K.845, T.846, K.848, N.851, E.852, Y.859
- Chain B: F.16, F.37
- Ligands: PCW.10, CLR.22
Ligand excluded by PLIPPCW.25: 3 residues within 4Å:- Chain A: L.351, R.358
- Chain C: K.62
Ligand excluded by PLIPPCW.26: 12 residues within 4Å:- Chain A: F.972, C.976, P.977
- Chain C: Y.37, R.40, V.41, L.44, I.45, A.48, C.51, V.52
- Ligands: PCW.27
Ligand excluded by PLIPPCW.27: 5 residues within 4Å:- Chain C: Y.37, V.49, I.53
- Ligands: PCW.26, PCW.28
Ligand excluded by PLIPPCW.28: 8 residues within 4Å:- Chain A: P.990, F.994
- Chain C: Y.34
- Ligands: PCW.12, CLR.24, PCW.27, CLR.44, PCW.48
Ligand excluded by PLIPPCW.30: 4 residues within 4Å:- Chain D: H.295, H.298, I.299
- Ligands: PCW.36
Ligand excluded by PLIPPCW.31: 18 residues within 4Å:- Chain D: I.865, Y.999, I.1002, L.1005, Y.1006, M.1009, I.1013, G.1020, W.1021, V.1022, Q.1024
- Chain E: K.35, L.38, F.39, F.43, L.47, I.50
- Ligands: CLR.9
Ligand excluded by PLIPPCW.32: 14 residues within 4Å:- Chain D: W.936, F.950, Q.951, G.953, M.954, K.955, T.967, F.997, S.1000, L.1001
- Ligands: PCW.13, PCW.33, CLR.44, PCW.48
Ligand excluded by PLIPPCW.33: 16 residues within 4Å:- Chain A: F.994, L.1001
- Chain B: T.61
- Chain D: R.946, S.948, F.950, Q.951, F.1004, L.1005, E.1008, F.1012, R.1015
- Ligands: CLR.9, PCW.12, PCW.13, PCW.32
Ligand excluded by PLIPPCW.34: 9 residues within 4Å:- Chain D: N.132, Y.136, V.140, V.810, C.814, L.817, V.822, A.982, L.983
Ligand excluded by PLIPPCW.35: 5 residues within 4Å:- Chain D: F.151, Y.154, V.347, T.350, K.354
Ligand excluded by PLIPPCW.36: 16 residues within 4Å:- Chain D: H.295, I.299, V.303, L.307, F.311, L.796, K.845, T.846, K.848, N.851, E.852, Y.859
- Chain E: F.16, F.37
- Ligands: PCW.30, CLR.42
Ligand excluded by PLIPPCW.45: 3 residues within 4Å:- Chain D: L.351, R.358
- Chain F: K.62
Ligand excluded by PLIPPCW.46: 12 residues within 4Å:- Chain D: F.972, C.976, P.977
- Chain F: Y.37, R.40, V.41, L.44, I.45, A.48, C.51, V.52
- Ligands: PCW.47
Ligand excluded by PLIPPCW.47: 5 residues within 4Å:- Chain F: Y.37, V.49, I.53
- Ligands: PCW.46, PCW.48
Ligand excluded by PLIPPCW.48: 8 residues within 4Å:- Chain D: P.990, F.994
- Chain F: Y.34
- Ligands: CLR.24, PCW.28, PCW.32, CLR.44, PCW.47
Ligand excluded by PLIP- 2 x ALF: TETRAFLUOROALUMINATE ION(Non-covalent)
ALF.17: 9 residues within 4Å:- Chain A: G.225, D.381, K.382, T.383, T.622, G.623, K.703, N.725
- Ligands: MG.18
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:D.381
ALF.37: 9 residues within 4Å:- Chain D: G.225, D.381, K.382, T.383, T.622, G.623, K.703, N.725
- Ligands: MG.38
1 PLIP interactions:1 interactions with chain D- Metal complexes: D:D.381
- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.18: 4 residues within 4Å:- Chain A: D.381, T.383, D.722
- Ligands: ALF.17
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:D.381, A:T.383, A:D.722
MG.38: 4 residues within 4Å:- Chain D: D.381, T.383, D.722
- Ligands: ALF.37
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:D.381, D:T.383, D:D.722
- 4 x NA: SODIUM ION(Non-functional Binders)
NA.19: 4 residues within 4Å:- Chain A: P.338, T.784, N.788, D.816
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.784
NA.20: 5 residues within 4Å:- Chain A: V.284, L.730, K.731, A.733, D.752
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.752
NA.39: 4 residues within 4Å:- Chain D: P.338, T.784, N.788, D.816
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:D.816
NA.40: 5 residues within 4Å:- Chain D: V.284, L.730, K.731, A.733, D.752
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:D.752
- 2 x 01: palytoxin
01.21: 28 residues within 4Å:- Chain A: L.115, A.119, I.122, Q.123, T.126, D.128, N.134, L.141, L.316, I.317, G.319, Y.320, S.321, W.322, L.323, E.324, I.327, V.334, A.335, V.337, E.339, E.791, F.795, F.798, L.805, T.809, I.812, D.816
21 PLIP interactions:21 interactions with chain A- Hydrophobic interactions: A:A.119, A:I.122, A:T.126, A:L.316, A:W.322, A:L.323, A:I.327, A:A.335, A:F.795, A:F.795, A:F.795, A:L.805, A:I.812
- Hydrogen bonds: A:N.134, A:L.316, A:I.317, A:I.317, A:G.319, A:E.324, A:E.324, A:A.335
01.41: 28 residues within 4Å:- Chain D: L.115, A.119, I.122, Q.123, T.126, D.128, N.134, L.141, L.316, I.317, G.319, Y.320, S.321, W.322, L.323, E.324, I.327, V.334, A.335, V.337, E.339, E.791, F.795, F.798, L.805, T.809, I.812, D.816
21 PLIP interactions:21 interactions with chain D- Hydrophobic interactions: D:A.119, D:I.122, D:T.126, D:L.316, D:W.322, D:L.323, D:I.327, D:A.335, D:F.795, D:F.795, D:F.795, D:L.805, D:I.812
- Hydrogen bonds: D:N.134, D:L.316, D:I.317, D:I.317, D:G.319, D:E.324, D:E.324, D:A.335
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kanai, R. et al., How palytoxin transforms the Na + ,K + pump into a cation channel. Proc.Natl.Acad.Sci.USA (2025)
- Release Date
- 2025-10-01
- Peptides
- Na, K-ATPase alpha subunit: AD
Na+,K+-ATPase beta subunit: BE
FXYD domain-containing ion transport regulator: CF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
CB
BE
DC
GF
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- NAG- MAN: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- FUC: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x CLR: CHOLESTEROL(Non-covalent)
- 22 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 2 x ALF: TETRAFLUOROALUMINATE ION(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 4 x NA: SODIUM ION(Non-functional Binders)
- 2 x 01: palytoxin
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kanai, R. et al., How palytoxin transforms the Na + ,K + pump into a cation channel. Proc.Natl.Acad.Sci.USA (2025)
- Release Date
- 2025-10-01
- Peptides
- Na, K-ATPase alpha subunit: AD
Na+,K+-ATPase beta subunit: BE
FXYD domain-containing ion transport regulator: CF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
CB
BE
DC
GF
E - Membrane
-
We predict this structure to be a membrane protein.